BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 31159323)

  • 1. Methylation Density Pattern of
    Fabrizio FP; Sparaneo A; Centra F; Trombetta D; Storlazzi CT; Graziano P; Maiello E; Fazio VM; Muscarella LA
    Int J Mol Sci; 2019 May; 20(11):. PubMed ID: 31159323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of KEAP1 Silencing on the Regulation of NRF2 Activity in Neuroendocrine Lung Tumors.
    Sparaneo A; Fabrizio FP; la Torre A; Graziano P; Di Maio M; Fontana A; Bisceglia M; Rossi A; Pizzolitto S; De Maglio G; Tancredi A; Grimaldi F; Balsamo T; Centra F; Manzorra MC; Trombetta D; Pantalone A; Bonfitto A; Maiello E; Fazio VM; Muscarella LA
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31126053
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Keap1/Nrf2 pathway in kidney cancer: frequent methylation of KEAP1 gene promoter in clear renal cell carcinoma.
    Fabrizio FP; Costantini M; Copetti M; la Torre A; Sparaneo A; Fontana A; Poeta L; Gallucci M; Sentinelli S; Graziano P; Parente P; Pompeo V; De Salvo L; Simone G; Papalia R; Picardo F; Balsamo T; Flammia GP; Trombetta D; Pantalone A; Kok K; Paranita F; Muscarella LA; Fazio VM
    Oncotarget; 2017 Feb; 8(7):11187-11198. PubMed ID: 28061437
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hypermethylation of the Keap1 gene in human lung cancer cell lines and lung cancer tissues.
    Wang R; An J; Ji F; Jiao H; Sun H; Zhou D
    Biochem Biophys Res Commun; 2008 Aug; 373(1):151-4. PubMed ID: 18555005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A possible gene silencing mechanism: hypermethylation of the Keap1 promoter abrogates binding of the transcription factor Sp1 in lung cancer cells.
    Guo D; Wu B; Yan J; Li X; Sun H; Zhou D
    Biochem Biophys Res Commun; 2012 Nov; 428(1):80-5. PubMed ID: 23047008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Frequent epigenetics inactivation of KEAP1 gene in non-small cell lung cancer.
    Muscarella LA; Parrella P; D'Alessandro V; la Torre A; Barbano R; Fontana A; Tancredi A; Guarnieri V; Balsamo T; Coco M; Copetti M; Pellegrini F; De Bonis P; Bisceglia M; Scaramuzzi G; Maiello E; Valori VM; Merla G; Vendemiale G; Fazio VM
    Epigenetics; 2011 Jun; 6(6):710-9. PubMed ID: 21610322
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methylation of the KEAP1 gene promoter region in human colorectal cancer.
    Hanada N; Takahata T; Zhou Q; Ye X; Sun R; Itoh J; Ishiguro A; Kijima H; Mimura J; Itoh K; Fukuda S; Saijo Y
    BMC Cancer; 2012 Feb; 12():66. PubMed ID: 22325485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic modifications but not genetic polymorphisms regulate KEAP1 expression in colorectal cancer.
    Gao L; Yuan F; Che G; Xiao X; Nie X; Wang Y; Jia J; Kong AN; Zhang L
    J Cell Biochem; 2019 Aug; 120(8):12311-12320. PubMed ID: 30825237
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genistein mediates the selective radiosensitizing effect in NSCLC A549 cells via inhibiting methylation of the keap1 gene promoter region.
    Liu X; Sun C; Liu B; Jin X; Li P; Zheng X; Zhao T; Li F; Li Q
    Oncotarget; 2016 May; 7(19):27267-79. PubMed ID: 27029077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epigenetic Scanning of
    Fabrizio FP; Mazza T; Castellana S; Sparaneo A; Muscarella LA
    Antioxidants (Basel); 2020 Sep; 9(9):. PubMed ID: 32971994
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MBD1 is an Epigenetic Regulator of KEAP1 in Pancreatic Cancer.
    Zhang B; Xu J; Li C; Shi S; Ji S; Xu W; Liu J; Jin K; Liang D; Liang C; Liu L; Liu C; Qin Y; Yu X
    Curr Mol Med; 2016; 16(4):404-11. PubMed ID: 26980696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic versus Genetic Deregulation of the KEAP1/NRF2 Axis in Solid Tumors: Focus on Methylation and Noncoding RNAs.
    Fabrizio FP; Sparaneo A; Trombetta D; Muscarella LA
    Oxid Med Cell Longev; 2018; 2018():2492063. PubMed ID: 29643973
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promoter DNA demethylation of Keap1 gene in diabetic cardiomyopathy.
    Liu ZZ; Zhao XZ; Zhang XS; Zhang M
    Int J Clin Exp Pathol; 2014; 7(12):8756-62. PubMed ID: 25674242
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinicopathological, microenvironmental and genetic determinants of molecular subtypes in KEAP1/NRF2-mutant lung cancer.
    Cai MC; Chen M; Ma P; Wu J; Lu H; Zhang S; Liu J; Zhao X; Zhuang G; Yu Z; Fu Y
    Int J Cancer; 2019 Feb; 144(4):788-801. PubMed ID: 30411339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated data analysis reveals significant associations of
    Elshaer M; ElManawy AI; Hammad A; Namani A; Wang XJ; Tang X
    Aging (Albany NY); 2020 Apr; 12(8):7183-7206. PubMed ID: 32327612
    [No Abstract]   [Full Text] [Related]  

  • 16. Epigenetic modulation of tumor suppressor CCAAT/enhancer binding protein alpha activity in lung cancer.
    Tada Y; Brena RM; Hackanson B; Morrison C; Otterson GA; Plass C
    J Natl Cancer Inst; 2006 Mar; 98(6):396-406. PubMed ID: 16537832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of SCT Methylation as a Hallmark Biomarker for Lung Cancers.
    Zhang YA; Ma X; Sathe A; Fujimoto J; Wistuba I; Lam S; Yatabe Y; Wang YW; Stastny V; Gao B; Larsen JE; Girard L; Liu X; Song K; Behrens C; Kalhor N; Xie Y; Zhang MQ; Minna JD; Gazdar AF
    J Thorac Oncol; 2016 Mar; 11(3):346-360. PubMed ID: 26725182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome.
    Draht MX; Smits KM; Jooste V; Tournier B; Vervoort M; Ramaekers C; Chapusot C; Weijenberg MP; van Engeland M; Melotte V
    Clin Epigenetics; 2016; 8():44. PubMed ID: 27118999
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of KEAP1 expression by promoter methylation in malignant gliomas and association with patient's outcome.
    Muscarella LA; Barbano R; D'Angelo V; Copetti M; Coco M; Balsamo T; la Torre A; Notarangelo A; Troiano M; Parisi S; Icolaro N; Catapano D; Valori VM; Pellegrini F; Merla G; Carella M; Fazio VM; Parrella P
    Epigenetics; 2011 Mar; 6(3):317-25. PubMed ID: 21173573
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Promoter demethylation of Keap1 gene in human diabetic cataractous lenses.
    Palsamy P; Ayaki M; Elanchezhian R; Shinohara T
    Biochem Biophys Res Commun; 2012 Jul; 423(3):542-8. PubMed ID: 22683333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.